Myth-buster
A meta-analysis of 19 studies found vitamin C failed to reduce short-term mortality in COVID-19 patients — a 0.92 risk ratio that could just as easily reflect chance.
This contradicts the popular belief that high-dose vitamin C is a life-saver in acute COVID-19, but because it's one of the first indexed meta-analyses on the topic and the data came from unblinded clinical settings, the picture is far from settled.
Researchers pooled 19 clinical studies on vitamin C for COVID-19 and found no statistical evidence it lowered the chance of dying in the short term. The risk ratio of 0.92 looks like a small possible benefit, but the wide confidence interval (0.72 to 1.17) means the true effect could range from a modest help to a slight harm — and the statistical test says this result is likely just noise. In-hospital mortality also showed no benefit, suggesting the theoretical anti-inflammatory promise of vitamin C didn't translate into a survival advantage in real-world hospital settings.
Where this fits in the evidence
This is among the first studies we've indexed on Vitamin C for Reduced Short-term Mortality — treat it as an early signal until more research accumulates.
The study
Efficacy of vitamin C in COVID-19 management: a systematic review and meta-analysis.
- Meta-Analysis
- n = 19
- 2025-10-31
- BMC infectious diseases
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.